Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 深圳信立泰药业股份有限公司（以下简称“信立泰”）成立于1998年，2009年在深交所上市（股票代码：002294），是一家立足中国、面向全球、研产销一体化的创新驱动型医药企业。信立泰坚守“为人类健康提供卓越的医药产品”的神圣使命，以优质创新产品和循证医学推广为核心竞争力，努力打造成为以心脑血管为主的慢病领域龙头企业。 信立泰先后承担“十一五”“十二五”“十三五”国家重大专项及国家、省、市的重大科技项目60余项，3次获“中国专利金奖”，荣获“国家技术创新示范企业”“中国医药研发产品线最佳工业企业”等荣誉。
Main Business 药品、医疗器械产品的研发、生产、销售。
Legal Representative 叶宇翔
Top Executives
董事长：叶宇翔
董事：陈茜渝,沈清,颜杰,杨健锋,叶宇翔,叶澄海
独立董事：刘来平,朱厚佳,王学恭
Top 5 Shareholder
Shareholder name Nature Holding Date
信立泰药业有限公司流通A股56.99%30/09/2024
中信证券资产管理（香港）有限公司－客户资金流通A股2.97%30/09/2024
深圳信立泰药业股份有限公司－第三期员工持股计划流通A股2.10%30/09/2024
香港中央结算有限公司流通A股2.02%30/09/2024
深圳市润复投资发展有限公司流通A股1.39%30/09/2024
Company Secretary 杨健锋
Solicitors 北京市金杜律师事务所
Auditors 大信会计师事务所（特殊普通合伙）
Tel No 0755-83867888
Fax No 0755-83867338
Website www.salubris.com
Email investor@salubris.cn
Company Address
Register: 深圳市福田区福保街道福保社区红柳道2号289数字半岛4层A区
Office: 广东省深圳市福田区深南大道6009号车公庙绿景广场主楼（B座）37层
Listing Date 10/09/2009
Shares Capital
Shares Capital: 1,114,816,535
Total A Share: 1,114,816,535
Listed A Share: 1,114,565,736
Non-tradable A Share: 250,799
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.520
DPS(RMB)* ¥ 0.500
NBV Per Share(RMB)* ¥ 7.193
Market Capitalization(RMB) 33.972B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.